09.09.2026, 17:46
Promomed launches flagship drug in Kazakhstan
MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.
To read the full news articles, Subscribe.
04:29PM
Uzbekistan Airports, My Freighter launch e-commerce goods delivery from China to Europe via Tashkent
03:21PM
Foreign leaders congratulate Tajik president on 35th anniversary of Tajikistan's independence
Archive
